Biotricity Stock Discussion

$Biotricity (BTCY.US)$
Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program
Biotricity (Nasdaq: BTCY) has launched a new cardiac monitoring pilot program with a prominent hospital group, covering 60 sites across multiple states. The company's three-channel connected solution offers superior diagnostics, reduced patient risk, and improved workflow efficiency, resulting in better clinical outcomes and lower healthcare costs.
This program positions Biotricity to acceler...

$Biotricity (BTCY.US)$ • Biotricity's fiscal year 2024 revenue rose to $12.06 million, a 25% increase, with Q4 revenue up 15.9% to $3.2 million.
• Gross profit for the quarter was $2.3 million, a 48% year-over-year increase, with a gross margin of 71.5%.
• Operating expenses decreased by 17%, and the company is aiming for EBITDA neutrality and profitability soon.
• Strategic initiatives included the launch of Biocore Pro and HeartSecure, partnerships with industry leaders, and ex...

$Biotricity (BTCY.US)$ Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
Accesswire· 1 min ago
Democratizing cardiac health with convenient, rapid, and reliable results

$Biotricity (BTCY.US)$
Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
Biotricity, a leader in Technology-as-a-Service (TaaS) for healthcare, has launched HeartSecure, a direct-to-consumer heart health screening service.
Heart disease is a major global health issue, with cardiovascular disease causing one death every 1.5...

$Biotricity (BTCY.US)$ Not even a great improvement YoY in earnings can get any volume! Hehehe! Now thats some pathetic interest

$Biotricity (BTCY.US)$ Biotricity Provides Year-End Guidance With Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
Accesswire· 
Company expects Loss from Operations to decrease by over 40% YoY and Margin Improvement by over 10% YoY
REDWOOD CITY, CA / ACCESSWIRE / June 6, 2024 / Biotricity Inc. (NASDAQ:BTCY), a leading Technology-as-a-Service (TaaS) company dedicated to disrupting the healthcare industry with cutting-edge medical and consumer diagnost...

$Biotricity (BTCY.US)$ Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares Into Restricted Common Stock
Accesswire· 6 mins ago
REDWOOD CITY, CA / ACCESSWIRE / June 4, 2024 / Biotricity Inc.] (NASDAQ:BTCY), a leading Technology-as-a-Service (TaaS) company dedicated to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, is thrilled to announce that the majority of it...

$Biotricity (BTCY.US)$
Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
Biotricity (NASDAQ: BTCY) announces the upcoming launch of HeartSecure, the first-ever direct-to-patient cardiac screening service. Targeting the $1.05 billion home heart health market, HeartSecure aims to provide home-based cardiac health checks for 127 million Americans at risk for heart disease. This service addresses l...

$Biotricity (BTCY.US)$
NEWS
Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics

$Biotricity (BTCY.US)$ NEWS: Biotricity Partners With a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 Out of Every 2 Hospitals in America